1. Home
  2. EYPT vs SPTN Comparison

EYPT vs SPTN Comparison

Compare EYPT & SPTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EYPT
  • SPTN
  • Stock Information
  • Founded
  • EYPT 1987
  • SPTN 1917
  • Country
  • EYPT United States
  • SPTN United States
  • Employees
  • EYPT N/A
  • SPTN N/A
  • Industry
  • EYPT Biotechnology: Laboratory Analytical Instruments
  • SPTN Food Distributors
  • Sector
  • EYPT Industrials
  • SPTN Consumer Discretionary
  • Exchange
  • EYPT Nasdaq
  • SPTN Nasdaq
  • Market Cap
  • EYPT 594.5M
  • SPTN 618.4M
  • IPO Year
  • EYPT 2005
  • SPTN N/A
  • Fundamental
  • Price
  • EYPT $7.48
  • SPTN $18.01
  • Analyst Decision
  • EYPT Strong Buy
  • SPTN Hold
  • Analyst Count
  • EYPT 8
  • SPTN 1
  • Target Price
  • EYPT $25.71
  • SPTN $20.00
  • AVG Volume (30 Days)
  • EYPT 922.9K
  • SPTN 333.6K
  • Earning Date
  • EYPT 03-06-2025
  • SPTN 02-13-2025
  • Dividend Yield
  • EYPT N/A
  • SPTN 4.83%
  • EPS Growth
  • EYPT N/A
  • SPTN 9.92
  • EPS
  • EYPT N/A
  • SPTN 1.33
  • Revenue
  • EYPT $45,713,000.00
  • SPTN $9,532,883,000.00
  • Revenue This Year
  • EYPT N/A
  • SPTN N/A
  • Revenue Next Year
  • EYPT N/A
  • SPTN $2.15
  • P/E Ratio
  • EYPT N/A
  • SPTN $13.55
  • Revenue Growth
  • EYPT 7.50
  • SPTN N/A
  • 52 Week Low
  • EYPT $6.90
  • SPTN $17.30
  • 52 Week High
  • EYPT $30.99
  • SPTN $23.00
  • Technical
  • Relative Strength Index (RSI)
  • EYPT 44.49
  • SPTN 42.39
  • Support Level
  • EYPT $7.15
  • SPTN $17.30
  • Resistance Level
  • EYPT $8.25
  • SPTN $18.31
  • Average True Range (ATR)
  • EYPT 0.66
  • SPTN 0.43
  • MACD
  • EYPT -0.01
  • SPTN 0.03
  • Stochastic Oscillator
  • EYPT 22.01
  • SPTN 51.82

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

About SPTN SpartanNash Company

SpartanNash Co is a food solutions company that delivers the ingredients. Its principal business activities include, distributing grocery products to a diverse group of independent and chain retailers, its corporate-owned retail stores, and U.S. military commissaries and exchanges; as well as operating a fresh produce distribution network and the Our Family private label brand. The company operates in two segments: Retail and Wholesale. Majority of the revenue is earned from its Wholesale segment which uses a multi-channel sales approach to distribute national brand and private brand products to independent retailers, national accounts, food service distributors, e-commerce providers, and the Company's corporate owned retail stores.

Share on Social Networks: